LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
9/30/2025 | 6/30/2025 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | – | -$14,181 | -$27,696 |
| Dep. & Amort. | – | – | $5 | $3 |
| Deferred Tax | – | – | $0 | $0 |
| Stock-Based Comp. | – | – | $0 | $339 |
| Change in WC | – | – | -$9,999 | $9,812 |
| Other Non-Cash | – | – | $2,138 | $1,765 |
| Operating Cash Flow | – | – | -$22,037 | -$15,777 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | – | -$443 | -$41 |
| Net Acquisitions | – | – | $0 | $0 |
| Inv. Purchases | – | – | $0 | -$3,729 |
| Inv. Sales/Matur. | – | – | $29,317 | $0 |
| Other Inv. Act. | – | – | $0 | $10,656 |
| Investing Cash Flow | – | – | $28,874 | $6,886 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | – | $0 | $0 |
| Stock Issued | – | – | $20 | $0 |
| Stock Repurch. | – | – | $0 | $0 |
| Dividends Paid | – | – | $0 | $0 |
| Other Fin. Act. | – | – | $0 | $3 |
| Financing Cash Flow | – | – | $20 | $3 |
| Forex Effect | – | – | -$6,857 | $0 |
| Net Chg. in Cash | – | – | $0 | -$8,888 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | – | $0 | $17,634 |
| End Cash | – | – | $0 | $8,746 |
| Free Cash Flow | – | – | -$22,480 | -$15,818 |